PubMed

A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease.

Halfon P, Imbert-Bismut F, Messous D, Antoniotti G, Benchetrit D, Cart-Lamy P, Delaporte G, Doutheau D, Klump T, Sala M, Thibaud D, Trepo E, Thabut D, Myers RP, Poynard T.

Comp Hepatol. 2002 Dec 30;1(1):3.PMID: 12537583 [PubMed - as supplied by publisher]Related articlesFree article

Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors.

Imbert-Bismut F, Messous D, Thibault V, Myers RB, Piton A, Thabut D, Devers L, Hainque B, Mercadier A, Poynard T.

Clin Chem Lab Med. 2004 Mar;42(3):323-33. Erratum in: Clin Chem Lab Med. 2004;42(6):681. Thibaut, Vincent [corrected to Thibault, Vincent]. PMID: 15080567 [PubMed - indexed for MEDLINE]Related articles

Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest).

Munteanu M, Messous D, Thabut D, Imbert-Bismut F, Jouys M, Massard J, Piton A, Bonyhay L, Ratziu V, Hainque B, Poynard T.

Comp Hepatol. 2004 Jun 23;3(1):3.PMID: 15214966 [PubMed - as supplied by publisher]Related articlesFree article

Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.

Rosenthal-Allieri MA, Tran A, Halfon P, Imbert-Bismut F, Munteanu M, Messous D, Peritore ML, Poynard T, Bernard A.

Gastroenterol Clin Biol. 2007 Oct;31(10):815-21.PMID: 18166859 [PubMed - indexed for MEDLINE]Related articlesFree article

Discordance between biochemical markers of liver activity and fibrosis (Actitest((R))-Fibrotest((R))) and liver biopsy in patients with chronic hepatitis C.

Fontanges T, Bailly F, Trepo E, Chevallier M, Maynard-Muet M, Nalet B, Beorchia S, Pillon D, Moindrot H, Froissart B, Slaoui M, Tinel X, Pradat P, Trepo C.

Gastroenterol Clin Biol. 2008 Sep 3. [Epub ahead of print]PMID: 18775614 [PubMed - as supplied by publisher]Related articlesFree article

Impact of quality control accepted inter-laboratory variations on calculated Fibrotest/Actitest scores for the non-invasive biochemical assessment of liver fibrosis.

Gressner OA, Beer N, Jodlowski A, Gressner AM.

Clin Chim Acta. 2009 Nov;409(1-2):90-5. Epub 2009 Sep 10.PMID: 19748500 [PubMed - indexed for MEDLINE]Related articles

[Results transferability on RXL, ARX, X-Pand, BN2 (Dade Behring) and modular DP (Roche Diagnostics) analysers: application to component assays of fibrotest and Actitest]

Imbert-Bismut F, Messous D, Raoult A, Poynard T, Bertrand JJ, Marie PA, Louis V, Audy C, Thouy JM, Hainque B, Piton A.

Ann Biol Clin (Paris). 2005 May-Jun;63(3):305-13. French. PMID: 15951262 [PubMed - indexed for MEDLINE]Related articlesFree article

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.

Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, Messous D, Charlotte F, Di Martino V, Benhamou Y, Poynard T.

J Hepatol. 2003 Aug;39(2):222-30.PMID: 12873819 [PubMed - indexed for MEDLINE]Related articles

Fibrotest-Actitest: the biochemical marker of liver fibrosis--the Israeli experience.

Morali G, Maor Y, Klar R, Braun M, Ben Ari Z, Bujanover Y, Zuckerman E, Boger S, Halfon P.

Isr Med Assoc J. 2007 Aug;9(8):588-91.PMID: 17877064 [PubMed - indexed for MEDLINE]Related articlesFree article

Intermethod calibration of alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) results: application to Fibrotest and Actitest scores.

Férard G, Piton A, Messous D, Imbert-Bismut F, Frairi A, Poynard T, Lessinger JM.

Clin Chem Lab Med. 2006;44(4):400-6.PMID: 16599832 [PubMed - indexed for MEDLINE]Related articles

Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.

Halfon P, Bourliere M, Deydier R, Botta-Fridlund D, Renou C, Tran A, Portal I, Allemand I, Bertrand JJ, Rosenthal-Allieri A, Rotily M, Sattonet C, Benderitter T, Saint Paul MC, Bonnot HP, Penaranda G, Degott C, Masseyeff MF, Ouzan D.

Am J Gastroenterol. 2006 Mar;101(3):547-55.PMID: 16542291 [PubMed - indexed for MEDLINE]Related articles

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C.

Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, Ratziu V, Mercadier A, Benhamou Y, Hainque B.

Comp Hepatol. 2004 Sep 23;3(1):8.PMID: 15387887 [PubMed - as supplied by publisher]Related articlesFree article

The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience.

Grigorescu M, Rusu M, Neculoiu D, Radu C, Serban A, Catanas M, Grigorescu MD.

J Gastrointestin Liver Dis. 2007 Mar;16(1):31-7.PMID: 17410286 [PubMed - indexed for MEDLINE]Related articlesFree article

[The prognostic tools of hepatitis C virus infections]

Halfon P, Ouzan D, Cattan L, Cacoub P.

Presse Med. 2004 Apr 24;33(8):542-3. Review. French. PMID: 15235511 [PubMed - indexed for MEDLINE]Related articles

Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients.

Rossi E, Adams L, Prins A, Bulsara M, de Boer B, Garas G, MacQuillan G, Speers D, Jeffrey G.

Clin Chem. 2003 Mar;49(3):450-4.PMID: 12600957 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus.

Poynard T, Ngo Y, Marcellin P, Hadziyannis S, Ratziu V, Benhamou Y; Adefovir Dipivoxil 437 and 438 Study Groups.

J Viral Hepat. 2009 Mar;16(3):203-13. Epub 2008 Oct 22.PMID: 19175871 [PubMed - indexed for MEDLINE]Related articles

Noninvasive assessment of hepatic fibrosis and necroinflammatory activity in Egyptian children with chronic hepatitis C virus infection using FibroTest and ActiTest.

El-Shabrawi MH, Mohsen NA, Sherif MM, El-Karaksy HM, Abou-Yosef H, El-Sayed HM, Riad H, Bahaa N, Isa M, El-Hennawy A.

Eur J Gastroenterol Hepatol. 2010 Jan 27. [Epub ahead of print]PMID: 20110820 [PubMed - as supplied by publisher]Related articles

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis.

Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, Messous D, Capron D, Abella A, Massard J, Ngo Y, Munteanu M, Mercadier A, Manns M, Albrecht J.

Comp Hepatol. 2005 Dec 23;4:10.PMID: 16375767 [PubMed]Related articlesFree article

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Thabut D, Le Calvez S, Messous D, Thibault V, Benhamou Y, Moussalli J, Ratziu V.

Clin Chem. 2004 Aug;50(8):1344-55. Epub 2004 Jun 10.PMID: 15192028 [PubMed - indexed for MEDLINE]Related articlesFree article

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.

Ratziu V, Massard J, Charlotte F, Messous D, Imbert-Bismut F, Bonyhay L, Tahiri M, Munteanu M, Thabut D, Cadranel JF, Le Bail B, de Ledinghen V, Poynard T; LIDO Study Group; CYTOL study group.

BMC Gastroenterol. 2006 Feb 14;6:6.PMID: 16503961 [PubMed - indexed for MEDLINE]Related articlesFree article